Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Breaking News
News & Press: Daily Updates

First human trial of DNA-based Zika vaccine shows promise

Wednesday, October 4, 2017   (0 Comments)

The first results from a human trial of the DNA-based Zika vaccine GLS-5700 showed it was safe and elicited a robust immune response in study participants. Results from the phase 1 trial were published today in the New England Journal of Medicine.  


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.